The identification of peroxisome proliferator-activated receptor alpha-independent effects of oleoylethanolamide on intestinal transit in mice

Neurogastroenterology and Motility

Volumn 21, Issue 4, 2009, Pages 420-429

  Cluny, N L ^a   Keenan, C M ^a   Lutz, B ^b   Piomelli, D ^c   Sharkey, K A ^a,d  

^a UNIVERSITY OF CALGARY   (Canada)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

Enteric nervous system; Intestinal motility; Oleoylethanolamide; Peroxisome proliferator activated receptor alpha; Stress enhanced motility

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; GLUCAGON LIKE PEPTIDE 1; N OLEOYLETHANOLAMINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; VANILLOID RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLON MOTILITY; CONTROLLED STUDY; GASTROINTESTINAL MOTILITY; GUINEA PIG; IMMUNOREACTIVITY; INTESTINE INNERVATION; INTESTINE MOTILITY; INTESTINE TRANSIT TIME; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; GASTROINTESTINAL MOTILITY; GLUCAGON-LIKE PEPTIDE 1; IMMUNOHISTOCHEMISTRY; MICE; MICE, KNOCKOUT; OLEIC ACIDS; PPAR ALPHA; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; TRPV CATION CHANNELS;

EID: 62449123202     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2008.01248.x     Document Type: Article

References (40)

1. Mandard S, Muller M, Kersten S. Peroxisome proliferator-activated receptor alpha target genes. Cell Mol Life Sci 2004 61 : 393 416.
2. Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 1996 137 : 354 66.
3. van den Bosch HM, Bunger M, de Groot PJ, van der Meijde J, Hooiveld GJ, Muller M. Gene expression of transporters and phase I/II metabolic enzymes in murine small intestine during fasting. BMC Genomics 2007 8 : 267.
4. Bunger M, van den Bosch HM, van der Meijde J, Kersten S, Hooiveld GJ, Muller M. Genome-wide analysis of PPAR alpha activation in murine small intestine. Physiol Genomics 2007 30 : 192 204.
5. Kliewer SA, Sundseth SS, Jones SA et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci USA 1997 94 : 4318 23.
6. Fu J, Gaetani S, Oveisi F et al. Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature 2003 425 : 90 3.
7. Lo Verme J, Fu J, Astarita G et al. The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol Pharmacol 2005 67 : 15 9.
8. Lo Verme J, Gaetani S, Fu J, Oveisi F, Burton K, Piomelli D. Regulation of food intake by oleoylethanolamide. Cell Mol Life Sci 2005 62 : 708 16.
9. Schmid PC, Zuzarte-Augustin ML, Schmid HH. Properties of rat liver N-acylethanolamine amidohydrolase. J Biol Chem 1985 260 : 14145 9.
10. Ueda N, Yamanaka K, Yamamoto S. Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance. J Biol Chem 2001 276 : 35552 7.
11. Guzman M, Lo Verme J, Fu J, Oveisi F, Blazquez C, Piomelli D. Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha). J Biol Chem 2004 279 : 27849 54.
12. de Fonseca FR, Navarro M, Gomez R et al. An anorexic lipid mediator regulated by feeding. Nature 2001 414 : 209 12.
13. Aviello G, Matias I, Capasso R et al. Inhibitory effect of the anorexic compound oleoylethanolamide on gastric emptying in control and overweight mice. J Mol Med 2008 86 : 413 22.
14. Capasso R, Matias I, Lutz B et al. Fatty acid amide hydrolase controls mouse intestinal motility in vivo. Gastroenterology 2005 129 : 941 51.
15. Marsicano G, Wotjak CT, Azad SC et al. The endogenous cannabinoid system controls extinction of aversive memories. Nature 2002 418 : 530 4.
16. Buckley NE, McCoy KL, Mezey E et al. Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor. Eur J Pharmacol 2000 396 : 141 9.
17. Varga A, Nemeth J, Szabo A et al. Effects of the novel TRPV1 receptor antagonist SB366791 in vitro and in vivo in the rat. Neurosci Lett 2005 385 : 137 42.
18. Kumar KG, Byerley LO, Volaufova J et al. Genetic variation in Glp1r expression influences the rate of gastric emptying in mice. Am J Physiol Regul Integr Comp Physiol 2008 294 : R362 71.
19. Cimini A, Benedetti E, Cristiano L et al. Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons. Neuroscience 2005 130 : 325 37.
20. Gaetani S, Oveisi F, Piomelli D. Modulation of meal pattern in the rat by the anorexic lipid mediator oleoylethanolamide. Neuropsychopharmacology 2003 28 : 1311 6.
21. Lambert DM, DiPaolo FG, Sonveaux P et al. Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB2 cannabinoid, as potential ligands for the cannabinoid receptors. Biochim Biophys Acta 1999 1440 : 266 74.
22. Ryberg E, Larsson N, Sjogren S et al. The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol 2007 152 : 1092 101.
23. Jonsson KO, Vandevoorde S, Lambert DM, Tiger G, Fowler CJ. Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide. Br J Pharmacol 2001 133 : 1263 75.
24. Izzo AA, Capasso R, Pinto L, Di Carlo G, Mascolo N, Capasso F. Effect of vanilloid drugs on gastrointestinal transit in mice. Br J Pharmacol 2001 132 : 1411 6.
25. Capasso R, Izzo AA, Fezza F et al. Inhibitory effect of palmitoylethanolamide on gastrointestinal motility in mice. Br J Pharmacol 2001 134 : 945 50.
26. Ahern GP. Activation of TRPV1 by the satiety factor oleoylethanolamide. J Biol Chem 2003 278 : 30429 34.
27. Overton HA, Babbs AJ, Doel SM et al. Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metab 2006 3 : 167 75.
28. Bonini JA, Borowsky BE, Adham N, Boyle N, Thompson TO (inventors). Methods of identifying compounds that bind to SNORF25 receptors. 2002. US Patent 6,468,756. B1 October 2002.
29. Tolessa T, Gutniak M, Holst JJ, Efendic S, Hellstrom PM. Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin. J Clin Invest 1998 102 : 764 74.
30. Lauckner JE, Jensen JB, Chen HY, Lu HC, Hille B, Mackie K. GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proc Natl Acad Sci U S A 2008 105 : 2699 704.
31. Fu J, Astarita G, Gaetani S et al. Food intake regulates oleoylethanolamide formation and degradation in the proximal small intestine. J Biol Chem 2007 282 : 1518 28.
32. Yang Y, Chen M, Georgeson KE, Harmon CM. Mechanism of oleoylethanolamide on fatty acid uptake in small intestine after food intake and body weight reduction. Am J Physiol Regul Integr Comp Physiol 2007 292 : R235 41.
33. Schwartz GJ, Fu J, Astarita G et al. The lipid messenger OEA links dietary fat intake to satiety. Cell Metab 2008 8 : 281 8.
34. Lin HC, Zhao XT, Wang L. Jejunal brake: inhibition of intestinal transit by fat in the proximal small intestine. Dig Dis Sci 1996 41 : 326 9.
35. Cann PA, Read NW, Brown C, Hobson N, Holdsworth CD. Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns. Gut 1983 24 : 405 11.
36. Sykes MA, Blanchard EB, Lackner J, Keefer L, Krasner S. Psychopathology in irritable bowel syndrome: support for a psychophysiological model. J Behav Med 2003 26 : 361 72.
37. Cao SG, Wu WC, Han Z, Wang MY. Effects of psychological stress on small intestinal motility and expression of cholecystokinin and vasoactive intestinal polypeptide in plasma and small intestine in mice. World J Gastroenterol 2005 11 : 737 40.
38. Okano S, Nagaya H, Inatomi N. Novelty stress increases fecal pellet output in mongolian gerbils: effects of several drugs. J Pharmacol Sci 2005 98 : 411 8.
39. Ditto B, Miller SB, Barr RG. A one-hour active coping stressor reduces small bowel transit time in healthy young adults. Psychosom Med 1998 60 : 7 10.
40. Enck P, Merlin V, Erckenbrecht JF, Wienbeck M. Stress effects on gastrointestinal transit in the rat. Gut 1989 30 : 455 9.